Ambitious critical-thinker focused on the development and commercialization of technical financial products, focused on the clinical trial industry.
In the first 3 years of Business Development with mdgroup from 2019 to 2022: Contract Executed revenue estimated $9.8m(yr1-$1.20m, Yr2-$2.70m, Yr3-$5.70m) total across the portfolio of patient travel, reimbursement, and home health clinical services.
in Late 2022, the spin-off Skyelarke was founded. As the founding BD member I implemented our CRM with the capabilities of automated proposal generation and detailed pipeline forecasting. Secured startup's first contract with an Oncology Sponsor and established an additional two MSA agreements with CRO companies as preferred vendors.